Taken together, the activation of AMPK (especially AMPKα1) is a key mediator linking obesity and impaired muscle regeneration, providing an effective drug target to facilitate muscle regeneration in obese and elderly populations7–9. This evidence concerns the gene PRKAA1 and obesity due to melanocortin 4 receptor deficiency.